Resolute is advancing a first-in-class platform of cytotoxics and radiotherapeutics for aggressive and hard to treat solid tumors.
Resolute Science's investors include National Cancer Institute, NuFund Venture Group.
Resolute Science is headquartered in San Diego, United States.
Resolute is advancing a first-in-class platform of cytotoxics and radiotherapeutics for aggressive and hard to treat solid tumors.
Resolute Science is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Resolute Science — Funding & Investors." VCBacked, February 3, 2025, https://www.vcbacked.co/company/resolute-science. Accessed September 30, 2026.
VCBacked. (2025). Resolute Science — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/resolute-science
{{cite web |title=Resolute Science — Funding & Investors |url=https://www.vcbacked.co/company/resolute-science |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated